VIDEO: Treatments in pipeline for alopecia areata

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

So in terms of treatments in the pipeline, there are two treatments that will hopefully be approved soon by the FDA, two new JAK inhibitors, ritlecitinib and deuruxolitinib, and then at different stages of the treatment pipeline, there are other targets and approaches being studied. These include other small molecules such as deucravacitinib and other approaches like biologics that are a little more targeted, such as dupilumab, both of which are in clinical trials as we speak.